Integrating China in the International Consortium for Personalized Medicine Project: A Glance

Cancer is one of the leading causes of death worldwide, and its prevalence continues to rise. Traditional cancer treatments such as chemotherapy and radiation therapy can have significant side effects, and they may not be effective for all patients. The field of personalized medicine has the potential to revolutionize cancer prevention and treatment by tailoring therapies to an individual patient’s specific genetic and molecular profile.

Despite the potential benefits of personalized medicine for cancer, there are still significant challenges to its widespread implementation. One of these challenges is the lack of alignment between policies in different regions of the world. To address this issue, the Integrating China in the International Consortium for Personalized Medicine (IC2PerMed) consortium, of which the World Federation of Public Health Associations (WFPHA) is a partner, has developed a common roadmap for personalized medicine for cancer to foster common approaches between the People’s Republic of China and the European Union (EU) on personalized medicine research, development, innovation, and policies.

The IC2PerMed consortium is an EU initiative that aims to promote the implementation of personalized medicine in prevention and care. The consortium brings together organizations, researchers, policymakers, and healthcare professionals to work towards a common goal of improving patients’ outcomes.

The IC2PerMed consortium’s roadmap for personalized medicine for cancer has been finalized and is being presented at a series of events, including WFPHA webinars, a dedicated workshop at the 17th World Congress on Public Health, and a high-level symposium held in Geneva, Switzerland, in conjunction with the World Health Assembly.

The high-level symposium brings together high-level policymakers, scientists, and Chief Executive Officers from international health-related organizations to discuss the importance of personalized medicine for cancer and beyond and the need for international collaboration to promote its implementation. The meeting also provides an opportunity to showcase the work of the IC2PerMed consortium.

Thank You to Outgoing Governing Council Member

The WFPHA recognizes the outstanding contributions and unwavering commitment of its Outgoing Governing Council (GC) member, Dr Jesus Gonzalez.

Dr Gonzalez, a surgeon from the Faculty of Medicine of the National Autonomous University of Mexico (UNAM), served the GC as a representative of the Americas region.

Dr Gonzalez’s tenure as a member of our GC has been marked by his exceptional dedication, expertise, and relentless efforts to promote global public health. The WFPHA expresses its sincere gratitude to him for his invaluable contributions, which have undoubtedly advanced the organization’s mission to promote and protect public health worldwide. His exceptional leadership, vision, and dedication have been a source of inspiration for colleagues and peers alike.

As Dr Gonzalez embarks on new endeavors, the WFPHA extends its heartfelt appreciation and wishes him a fruitful journey ahead, confident in his ability to continue making a significant difference in the field of public health.

Big Tobacco’s Dirty Tricks

Since its inception, the tobacco industry has been at the forefront of influencing public opinion and disrupting health policy through various sophisticated and deceptive methods. As evidence has mounted supporting the undisputed deadly effects of tobacco products, the industry has found ways to adapt and thrive. They have succeeded in attracting enough new smokers to support industry growth despite losing eight million of their consumers annually to tobacco-related deaths. The sphere of influence of multi-billion dollar tobacco companies extends to the fields of scientific research, politics, law, education, and the media.

The WFPHA Tobacco Control Working Group has published a casebook entitled Big Tobacco’s Dirty Tricks: A Casebook of Seven Key Tactics Used by the Tobacco Industry which contains seven articles discussing key tactics used by tobacco corporations to improve their brand, hinder their opponents, and undermine tobacco control measures globally. The cases provide insights into the industry’s methods as they trick, manipulate, bribe, and threaten in the eternal quest for profit. Each article outlines a particular tactic, demonstrates examples where it has occurred, and offers recommendations for how individuals, professionals, organizations and governments can recognize and counteract them.

To evaluate readers’ feedback on the articles and investigate attitudes toward the tobacco industry tactics, a brief survey is provided. The quick anonymous survey can be accessed with the link below.

The more informed our society is about the tactics used by Big Tobacco, the better chance we have of effectively imposing tobacco control measures, reducing consumption globally and preventing tobacco-related illness and death.

Welcoming New Members

On May 19, 2022, during the General Assembly of the World Federation of Public Health Associations, member organizations have welcomed 3 new members; the Eastern Mediterranean Public Health Network (EMPHNET), the European Network of Medical Residents in Public Health (EuroNet MRPH), and World Patients Alliance.

We look forward to working together towards our shared goals of protecting and promoting health & wellbeing worldwide.

Welcoming New President

On May 19, 2022, the WFPHA formally welcomes its new President Prof. Luis Eugenio de Souza. He will hold the role of President for the next two years.

Luis is a professor at the Federal University of Bahia and a leader in health equity and sustainable development!